Freshness Index 2025: Big Pharma’s Aging Portfolio Problem Is Getting Worse
Big pharma companies must replenish aging portfolios with innovative therapies. This is no easy task and the numbers suggest the industry is falling further behind.
Scrip - August 4, 2026

Could Blister Packs Finally Be Recycled at Scale?
Industry-led sustainable packaging collective CiPPPA has launched CircuBack, a UK take-back scheme designed to create a credible route for collecting and recycling empty blister packs from consumers.
HBW Insight - August 4, 2026

Global Medtech Guidance Tracker: July 2026
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 90 documents have been posted on the tracker since its last update.
Medtech Insight - August 4, 2026

KKR’s $5.7Bn Bet On Integer Reopens The Door For Private Equity In Medtech
KKR's $5.7bn take-private of Integer Holdings reflects a broader private equity push into medtech, with depressed valuations and non-cyclical revenue making device contract manufacturers an increasingly attractive target for financial sponsors.
Medtech Insight - August 4, 2026

Accelerating Influenza Development: Lessons from a Novel Influenza Prevention Candidate
How can the right clinical development strategy help accelerate progress from early proof of concept to later-stage trials?
Scrip - August 4, 2026

Bayer Slams Germany’s Pricing Approach As It Lays Out Asundexian Launch Plans
Bayer’s CEO Bill Anderson has raised concerns around pricing policy in Germany as the German major gears up to launch its potential blockbuster asundexian.
Scrip - August 4, 2026

Off-Patent, On Record: View Through The Journalist’s Lens With Generics Bulletin’s Dave Wallace
Generics Bulletin senior reporter Urt? Fultinavi?i?t? is joined by executive editor Dave Wallace for the inaugural episode of new interview podcast series “Off-Patent, On Record” to discuss how the generics and biosimilars industries have changed over the past decades.
Generics Bulletin - August 4, 2026

UK Hydrocortisone Appeal Loss Strengthens CMA Hand In Excessive Pricing Cases
The Court of Appeal upheld the CMA’s excessive-pricing and dominance findings against hydrocortisone suppliers, ruling that falling prices and new entry did not end the abuse, while sending the penalties back to the CAT for a fuller review.
Generics Bulletin - August 4, 2026

Will A Patent Cliff Spark The Biggest Merger Of All Time?
Bristol Myers Squibb’s looming patent cliff puts nearly 70% of its first-half revenues at risk, raising doubts over whether its pipeline can offset the decline of Eliquis, Opdivo and other major franchises.
Generics Bulletin - August 4, 2026

Podcast: China’s Evolving Role in Global Clinical Development
How shifting perceptions and new opportunities are changing the way sponsors approach China
Scrip - August 4, 2026

What Next After Indian Regulator’s Hammer Falls On Ethics Committees?
Are clinical trial disruptions or drug shortages expected as the Indian drug regulator recently made unprecedented public disclosures of punitive measures against eight ethics committees after cancelling licenses of some production units earlier this year? Scrip spoke to experts
Scrip - August 4, 2026

Biotech Investors Are Waiting For The Wrong Milestone In AI Drug Discovery
Converge Bio's Dov Gertz says the value in AI drug discovery compounds at the platform layer, years before a candidate meets a regulator, and the milestones that reveal it can be measured now.
In Vivo - August 4, 2026

Over The Counter: Realizing Growth Through Pharmacy, With Simon-Kucher
In this episode of HBW Insight’s Over the Counter podcast, Simon-Kucher’s Christian Danelund and Chris Rebholz discuss the consultancy's Better Health Report and value of pharmacists to the consumer health industry.
HBW Insight - August 4, 2026

Hemispheric Bets AI Can Give The Brain Its First Objective Test
Fresh out of stealth with $52m, the NeuroAI startup Hemispheric says its Descartes model can decode EEG into clinical insights.
Medtech Insight - August 4, 2026

L’Oréal Outlines ‘Ambitious’ Gucci Beauty Plans
L'Oréal reported strong first-half results and laid out ambitious plans for its newly licensed Gucci beauty brand, with first products expected in 2028.
HBW Insight - August 4, 2026

Nicotine, Tobacco Researchers Suggest Doctors Recommend E-Cigarettes For Smoking Cessation
E-cigarettes “are less harmful than cigarettes and have been shown to be more effective for smoking cessation” than FDA-approved NRTs but “misperceptions of the harms of e-cigarettes are common among clinicians,” says Society for Research on Nicotine and Tobacco.
HBW Insight - August 4, 2026